By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ChanTest Corporation 

14656 Neo Parkway

Cleveland  Ohio  44128  U.S.A.
Phone: 216-332-1665 Fax: 216-332-1706



Company News
ChanTest Corporation CEO Named Distinguished Service Award Recipient by the Safety Pharmacology Society 7/24/2013 7:32:03 AM
BioFocus DPI Expands Ion Channel Offering Through Agreement With ChanTest Corporation 2/6/2013 10:37:04 AM
ChanTest Corporation Goes Beyond GLP to Become First Ion Channel and GPCR CRO With Cgmp Testing Capability 1/14/2013 9:28:33 AM
ChanTest Corporation Announces Drug Discovery Services Using the Enamine Ltd. 3D Compound Library 10/16/2012 10:12:20 AM
ChanTest Corporation Awarded $1 Million Grant for Predictive Assays Using Stem Cell-Derived Human Cardiomyocytes 9/18/2012 10:47:56 AM
ChanTest Corporation Hires Chris Mathes as Chief Commercial Officer 8/17/2012 10:16:59 AM
ChanTest Corporation Sponsors Great Strides Walk for Cystic Fibrosis 5/8/2012 10:20:43 AM
Roche (RHHBY), ChanTest Corporation Collaborate for Preclinical Cardiac Safety Testing of Drug Compounds Using iCell Cardiomyocytes and xCELLigence RTCA Cardio Instrument 12/5/2011 7:32:13 AM
ChanTest Corporation Signs Research Collaboration Agreement with The FDA 6/9/2011 8:50:58 AM
ChanTest Corporation First To Offer New High Throughput Electrophysiology Platform Validated for Both VGICs and LGICs 4/6/2011 10:41:39 AM